2009-07-02
Patriot Scientific Corporation Announces Smith & Nephew’s Purchase Of A Moore Microprocessor Patent™ Portfolio License
July 1, 2009 -- CARLSBAD, Calif.-- Patriot Scientific Corporation (OTC BB:PTSC) announced today that Smith & Nephew has purchased a Moore Microprocessor Patent™ (MMP) Portfolio license from The TPL Group. Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management, and joins a distinguished list of global systems manufacturers that have become MMP Licensees.
The MMP Portfolio patents cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment and automobiles which today have dozens of microprocessor-based key features and benefits.
About the MMP Portfolio
The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
About Patriot Scientific
Headquartered in Carlsbad, California, Patriot Scientific Corporation provides data sharing and secure data solutions for a connected world. Patriot Scientific addresses the expanding market opportunities in the healthcare, justice and public safety industries through its wholly owned subsidiary Patriot Data Solutions Group, Inc. These growth activities are funded with revenues generated, in a large part, from the continuing successful Moore Microprocessor Patent™ Portfolio licensing partnership with The TPL Group. Patriot Scientific’s integrated core intelligence solution addresses the critical data/information sharing needs of the healthcare industry, the Department of Homeland Security, the Department of Justice, and federal, state, and local public safety and law enforcement agencies. For more information on Patriot Scientific Corporation, visit: www.ptsc.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Next >
Forward-Looking Statements: Patriot Scientific does not routinely undertake to publicly update or revise its forward-looking statements, even if experience or future changes make it clear that any projected results (expressed or modified) will not be realized.
Forward-Looking Information: The statements in Patriot Scientifics news releases and public filings may contain forward-looking information within the meaning of the Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks, assumptions and uncertainties. In each case, actual results may differ materially from such forward-looking statements. Any statements regarding targets for future results are forward-looking, and actual results may differ materially. These are the company's targets, not predictions of actual performance.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this information contain statements forward looking in time which involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Receive News & Investor Updates
Please enter your email address to recieve news & investor updates
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it Patriot Scientific Corporation
6183 Paseo Del Norte, Suite 180
Carlsbad, CA 92011
Telephone: (760) 547-2700
Facsimile: (760) 547-2705
info@ptsc.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Patriot Family of Companies and Partners
*
*
patriotscientific.com/...mp;task=view&id=228&Itemid=29